Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Red yeast rice + atorvastatin represents a combination of a dietary supplement (red yeast rice) with a prescription statin medication (atorvastatin). This combination is generally not recommended by healthcare professionals due to potential safety concerns. Red yeast rice contains monacolin K, which is chemically identical to the prescription drug lovastatin. When combined with atorvastatin (Lipitor), this creates a situation where a patient would effectively be taking two statin medications simultaneously, which could increase the risk of side effects without providing proportional benefits[2][5]. While some research has investigated adding red yeast rice to statin therapy, the safety profile of this specific combination remains concerning. A triple-blind randomized clinical trial found that adding red yeast rice to statin medications significantly decreased total cholesterol, but showed no significant effect on other lipid profile components[1]. ## Safety Concerns The combination carries several potential risks: 1. **Increased risk of statin side effects**: Both components can cause similar adverse effects including muscle pain, liver damage, and kidney problems[2][3][5]. 2. **Unpredictable dosing**: Red yeast rice supplements vary widely in their monacolin K content, making it difficult to control the total statin dose when combined with atorvastatin[3]. 3. **Drug interactions**: The combination may interact with the same medications that statins typically interact with, including blood thinners, certain antibiotics, antifungals, and other medications[4][5]. According to the search results, this combination is classified as a "Moderate Drug Interaction" where it's usually advised to avoid the combination except under special circumstances[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on red yeast rice + atorvastatin.